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Controlling protein interactions at the implanted electrode interface is becoming an important 
strategy for the management of foreign body responses that have proven to be detrimental to the 
long-term performance of neural prosthesis. In this study, PEGylation was conducted on 
platinum bio-electrodes to render the surface protein-resistant. The PEGylated electrode was 
investigated using a quartz crystal microbalance-dissipation, electrochemical impedance 
spectroscopy and cyclic voltammetry.   
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The therapeutic efficacy of a chronically implanted neural prosthesis, such as the cochlear 
implant, is determined by the ability to effectively transfer charge across the electrode-tissue 
interface. A key factor is the host foreign body response that gives rise to fibrotic tissue 
encapsulation of the neural probe, consequently insulating the electrode from targeted neurons. 
Foreign body response typically arises from a biological cascade of non-desirable reactions, and 
is triggered by non-specific protein adsorption at the device interface. Controlling the protein 
interactions at the implanted electrode interface is thus becoming an important strategy for the 
management of adverse tissue responses around the device. 
 
PEGylation is orignially a pharmeceutical term, referring to covalent modification of 
protein/peptide drugs with poly(ethylene glycol) derivatives (PEG, FDA-approved). There are 
more than 8 PEGylated phamarceuticals receiving regulatory approval by the US and/or EU.1 
PEG is well-known for low toxicity and immunogenicity; it is highly soluble in water, and forms 
a conformational cloud with high hydration numbers and polymer chain mobility, which is 
responsible for excellent protein-resistant properties.2 In addition to drug delivery, PEG has been 
intensively explored as biocompatible, anti-fouling coatings for medical implants to improve the 
in vivo efficacies.3 
 
The work reported here is a natural follow-up of our bioenginering effort involving the surface 
modification of cochlear implants for enhanced electro-neural interfacing4. PEGylation was 
conducted on platinum electrodes to render the surface protein-resistant. The resultant PEG 
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coating was investigated in terms of quartz crystal microbalance-dissipation (QCM-D), 




mPEG thiols (Mw 5000 Da) were purchased from Jenkem Technology Co., Ltd, China. 
Potassium hexacyanoferrate (III), potassium nitrate, bovine serum albumin (BSA) and fibrinogen 
from bovine plasma were from Sigma-Aldrich, Australia. Pt electrodes (0.5 mm diameter), 
similar size close to the electrode pad in cochlear implants, were custom-made from CH 
Instrument, Inc., USA. Artificial perilymph solution (ARF, pH 7.4) was prepared to simulate the 
body fluid in the cochlea, comprising NaCl (7.39 g/L), KHCO3 (0.35 g/L), NaHCO3 (2.02 g/L), 
CaCl2 (0.08 g/L) and NH2C(CH2OH)3 (0.61 g/L). 
 
Pt electrodes were polished using aqueous alumina slurry, and cleaned using cyclic voltammetry 
in 0.5 M H2SO4 between -250 and 1200 mV (vs. an Ag│AgCl). The rinsed electrodes were 
treated with a deoxygenated mPEG thiol solution in Milli-Q water (1.0 mM) overnight at room 
temperature, rinsed and dried with N2 and denoted as Pt-PEG.  
 
2.2 QCM-D measurements  
QCM-D measurements were undertaken using a Q-Sense E4 system (Q-Sense AB, Sweden) 
equipped with a multichannel peristaltic pump (IPC Ismatec SA, Switzerland). The QCM sensor 
was an AT-cut quartz-crystal with a 10 mm diameter Pt electrode with a fundamental resonance 
frequency of 5 MHz. For PEGylation, the Pt-coated sensor was equilibrated in Milli-Q water, 
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followed by the introduction of mPEG thiol (1.0 mM in Milli-Q water) over 4 h, and then a rinse 
with Milli-Q water until stabilised. For protein adsorption, both bare and PEGylated sensors 
were equilibrated in ARF (for BSA) or 0.9 wt% NaCl (for fibrinogen), loaded with a BSA 
solution in ARF (2.8 mg/mL) or a fibrinogen solution in 0.9 wt% NaCl (1.0 mg/mL) for 4 h, and 
then rinsed with ARF (for BSA) or 0.9 wt% NaCl (for fibrinogen) until stabilised. The Voigt 
model was selected to determine the hydrated layer mass (ng/cm2) and thickness of the PEG or 
absorbed protein adlayers, using the 5th, 7th and 9th overtones.6 The Q-tools software package 
v.3.0.10.286 (Biolin Sci, AB) was used for data modelling, with the input parameters for the 
layer density (1027 kg/m3), fluid density (1020 kg/m3), layer viscosity (10-5 ≤ 10-2 kg/ms), layer 
shear modulus (104 ≤ 107 Pa), and mass (102 ≤ 105 ng/cm2).6  
 
2.3 Electrochemical characterisation 
A three-electrode electrochemical cell was used for all the electrochemical measurements, 
consisting of a Pt or Pt-PEG working electrode, a platinum mesh auxiliary electrode and an 
Ag│AgCl (3.0 M NaCl) reference electrode. EIS measurements were conducted on a Gamry EIS 
3000TM, at open-circuit potential with AC amplitude of 10 mV. CV experiments were performed 
using an EDAQ e-corder® electrochemical analysis system (EDAQ Pty Ltd, Australia). 
 
3. Results and discussion 
3.1 QCM-D 
PEGylation of Pt electrode is realized via the formation of sulfur-platinum bonds7. QCM-D was 
employed to monitor the PEGylation process and protein adsorption behavior through changes in 
resonance frequency (∆ƒ, coupled to layer hydrated mass) and energy dissipation (∆D, coupled 
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to layer viscoelasticity). Injecting an mPEG thiol-containing solution onto a Pt-coated sensor 
elicits an immediate decrease in frequency (Fig. 1A), suggesting a rise in the layer mass 
attributable to the attached PEG and associated water, and the change in solute density above the 
sensor. This is followed by a slow small rise in frequency attributed to mass loss arising from 
dehydration of the resultant adlayer as a result of a further increased density of surface grafted 
PEG8. Rinsing the modified sensor with deionized water produces a further increase in frequency 
until it reaches a plateau, as a result of the removal of any reversibly bound PEGs, as well as the 
solute density change above the sensor.  
 
The pronounced concurrent increase in dissipation upon PEGylation highlights the soft nature of 
the water-rich PEG coating. The dissipation for the PEG adlayer reaches its maximum after ~30 
minute exposure to the mPEG thiol. The PEG adlayer is deemed a viscoelastic hydrogel due to 
the high degrees of hydration of PEG.9,10 For instance, a number of studies reported on ≥ ~80 
wt% water contents for surface-grafted PEGs.11,12 By modeling the frequency and dissipation 
shifts using the viscoelastic Voigt model, the thickness and mass of the hydrated PEG were 
determined to be 8.0±0.4 nm and 822±46 ng/cm2, respectively.  
 
Albumin and fibrinogen were selected for protein adsorption studies. Albumin is one of the most 
abundant proteins in inner ear fluids13; while fibrinogen is a serum protein, playing a critical role 
in promoting inflammatory reactions to biomaterial implants14. The time-resolved adsorption 
kinetics of BSA and fibrinogen at a Pt electrode interface (Fig. 1B and C) illustrated the mass 
uptake took place predominantly within the first 10-15 minute protein exposure. After a thorough 
rinse to remove any weakly bound protein, the thickness and mass of the stabilized proteinaceous 
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layers are 6.3±0.4 nm and 719±43 ng/cm2 for BSA, and 16.1±0.1 nm and 1855±1 ng/cm2 for 
fibrinogen. The much higher uptake of fibrinogen, in comparison to BSA, is consistent with its 
larger molecular size and increased hydrophobicity. Further insight into the Pt interface modified 
either by the PEG or protein layer was obtained by examining the endpoint ∆D per respective 
adlayer mass (∆m), ∆D/∆m. In comparison to that of the PEG layer, the endpoint ∆D/∆m value 
decreases by a factor of 2.6 for the BSA layer, and by a factor of 3.0 for the fibrinogen layer 
(Fig. 1D). This implies that the adsorbed BSA or fibrinogen on Pt surface constitute a much 
stiffer layer, possibility with a lower water content.15 
 
The PEGylated Pt interface demonstrates excellent resistance to both BSA and fibrinogen 
adsorption (Fig. 1B and C), with a typical endpoint ∆ƒ of <~2 for BSA uptake, and ~7.2 Hz for 
fibrinogen uptake. When fitted using the Voigt model, these correspond to a mass below ~27 
ng/cm2 for the absorbed BSA, and ~157 ng/cm2 for the absorbed fibrinogen, indicating ≥~92% 
inhibition of protein adsorption at the electrode interface by PEGylation. However, these values 
serve only as a rough estimation, given the difficulty to attain accurate mass for modeling such 
small frequency changes.  
 
3.2 Electrochemical characterization 
Fig. 2A-D compares the CVs of bare and PEGylated Pt electrodes in 10 mM K3Fe(CN)6 before 
and after protein adsorption. The bare electrode CV shows quasi-reversible oxidation and 
reduction of the Fe(CN)63-/Fe(CN)64- at +285 and +150 mV, respectively (Fig. 2A). PEGylation 
of the electrode surface results in a small decrease in the peak currents (e.g., ipcPt-PEG/ipcPt = 0.93) 
and an increase in peak separation, reflecting an increased charge transfer resistance surface due 
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to the presence of PEG layer. The shape of the CV then remains largely unchanged upon 
exposure to BSA or fibrinogen (Fig. 2B). By contrast, the CV of the bare Pt electrode after 
exposure to BSA or fibrinogen becomes plateau-shaped with a pronounced reduction in the 
currents, emphasizing a strong blocking effect of the adsorbed proteinaceous layer (Fig. 2C). The 
retained electron transfer capability of the PEGylated electrode surface in a protein-rich 
environment as demonstrated in Fig. 2D, highlights the anti-fouling nature of the modified 
electrode interface, which is in good agreement with our QCM-D results. It is worthwhile to 
mention that the electrochemical behaviour of a redox probe chosen will depend on the chemical 
interactions of both redox states with the electrode surface.16,17 The use of ferri-ferrocyanide as a 
redox probe in this study is justified as it allows comparison with a number of other studies that 
use the same probe18,19. 
 
PEGylation of the Pt electrode produces a moderate increase in impedance over a broad 
frequency range below ~104 Hz (Fig. 3A), and a negative shift in phase angle at 102–105 Hz (Fig. 
3B). PEGylation also causes a small decrease in phase angle in the lower frequency region of 
0.1-10 Hz. These characteristics are consistent with the presence of PEG at the electrode surface 
that reduces both the double layer capacitance and electrode conductance. For instance, 
PEGylation results in a decrease of ~54% at 1 kHz and ~40% at 10 kHz in double layer 
capacitance, and a decrease of ~49% at 1 kHz and ~59% at 10 kHz in electrode conductance. For 
cochlear implant electrodes, high-frequency impedance (≥ 1 kHz) is of importance as auditory 
neural stimulation wherein biphasic current pulses with 25-100 µs pulse width can be 
employed.20 In this study, PEGylation elicits a more notable increase in the high-frequency 
impedance than protein adsorption, e.g., an increase of ~90% in impedance at 1 kHz and ~30% 
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at 10 kHz by PEGylation, as opposed to an increase of ~21% at 1 kHz and ~11% at 10 kHz by 
fibrinogen adsorption (Fig. 3C). The PEGylated electrode shows negligible changes in 
impedance after exposure to fibrinogen (Fig. 3D). Therefore it seems that the protein-resistant 
property of the PEGylated electrode is achieved with compromised impedance. However, this 
conclusion was drawn based on the result obtained in a much simplified in vitro condition. For 
cochlear implants, the in-vivo impedance has shown to be governed predominantly by the 
biological environment surrounding the electrode, such as fibrotic tissue response, and increase 
up to 6-7 folds after a 12-week implantation.21,22 The strategy of PEGylation reported here 
provides some control over the evolution of the electrode-tissue interface by minimizing non-
specific protein adsorption and subsequent foreign body response. Since the nature of this 
interface is critical to longer-term performance in-vivo studies are warranted in the future. 
 
4. Conclusions 
A simple method was developed for PEGylation of Pt bio-electrodes. The immobilized PEG 
coating is highly hydrated and permeable, with a thickness of ~ 8 nm, and can inhibit ≥ ~92% 
adsorption of both BSA and fibrinogen. Optimisation of the coating properties in terms of the in-
vivo electrode performance is required in the future, and the knowledge gained will provide a 
basis to facilitate the ongoing development of cochlear implants, as well as other types of neural 
prostheses for improved electro-neural interfacing.  
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Fig. 3. The IZI (A) and phase angle (B) plots of bare and PEGylated Pt electrodes; (C) comparison of the 
impedance of Pt before and after fibrinogen adsorption (Pt + fibrinogen); (D) comparison of the 
impedance of PEGylated Pt electrode before (Pt-PEG) and after fibrinogen adsorption (Pt-PEG + 
fibrinogen). EIS was undertaken at open-circuit potential in air-purged ARF at room temperature, over 
the frequency range of 0.1-100 kHz with AC amplitude of 10 mV. Protein adsorption procedure: Pt/PEG-
Pt electrode was soaked in a fibrinogen solution (1.0 mg/mL) in 0.9 wt% NaCl for 2 h, and then rinsed 
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